Search

Zoological science is an intricate field which requires intimate considerations and guidelines to make sure that limits and boundaries are set for the ethical and humane conduction of research. A number of bioethical laws and international conventions have been designed by bioethical and committees and review boards that serve as moral compass steering towards responsible and humane scientific research. Animal Welfare Act (AWA) sets standards for the responsible treatment of animals in research, transport, exhibition and animal dealers, handling and research protocols, Guide for the Care and Use of Laboratory Animals that is published by National research Council of Unites States provides a framework for the proper use and optimal care of animals for in vivo research in laboratory experiments [1]. Similarly, European Union Directive 2010/63/EU is a directive which outlines the standards for the animal protection used for research purposes in the Europe. It states 3Rs of animal testing i.e., Refinement, Reduction and Replacement, and necessitates that researchers consider alternatives before resorting to the animal experiments. An elaborate directive, Declaration of Helsinki, primarily focuses on human research ethics but has principle related o animal research ethics as well [2]. Likewise, another Convention on International Trade in Endangered Species of Wild Fauna and Flora also called as CITES, deals with the trade of endangered animals ensuring that any research which involves endangered species is conducted ethically with proper permits and prevents illegal and unethical exploitation of animals [3]. Last but not the least, the ARRIVE guidelines provide a checklist of essential information which must be included while publishing the research data which describes animal experiments, promotes transparency and improve the quality of reporting in the animal research. The current global conditions necessitate ethical consciousness in zoological research. These consid

Zoological science is an intricate field which requires intimate considerations and guidelines to make sure that limits and boundaries are set for the ethical and humane conduction of research. A number of bioethical laws and international conventions have been designed by bioethical and committees and review boards that serve as moral compass steering towards responsible and humane scientific research. Animal Welfare Act (AWA) sets standards for the responsible treatment of animals in research, transport, exhibition and animal dealers, handling and research protocols, Guide for the Care and Use of Laboratory Animals that is published by National research Council of Unites States provides a framework for the proper use and optimal care of animals for in vivo research in laboratory experiments [1]. Similarly, European Union Directive 2010/63/EU is a directive which outlines the standards for the animal protection used for research purposes in the Europe. It states 3Rs of animal testing i.e., Refinement, Reduction and Replacement, and necessitates that researchers consider alternatives before resorting to the animal experiments. An elaborate directive, Declaration of Helsinki, primarily focuses on human research ethics but has principle related o animal research ethics as well [2]. Likewise, another Convention on International Trade in Endangered Species of Wild Fauna and Flora also called as CITES, deals with the trade of endangered animals ensuring that any research which involves endangered species is conducted ethically with proper permits and prevents illegal and unethical exploitation of animals [3]. Last but not the least, the ARRIVE guidelines provide a checklist of essential information which must be included while publishing the research data which describes animal experiments, promotes transparency and improve the quality of reporting in the animal research. The current global conditions necessitate ethical consciousness in zoological research. These consid

Zoological science is an intricate field which requires intimate considerations and guidelines to make sure that limits and boundaries are set for the ethical and humane conduction of research. A number of bioethical laws and international conventions have been designed by bioethical and committees and review boards that serve as moral compass steering towards responsible and humane scientific research. Animal Welfare Act (AWA) sets standards for the responsible treatment of animals in research, transport, exhibition and animal dealers, handling and research protocols, Guide for the Care and Use of Laboratory Animals that is published by National research Council of Unites States provides a framework for the proper use and optimal care of animals for in vivo research in laboratory experiments [1]. Similarly, European Union Directive 2010/63/EU is a directive which outlines the standards for the animal protection used for research purposes in the Europe. It states 3Rs of animal testing i.e., Refinement, Reduction and Replacement, and necessitates that researchers consider alternatives before resorting to the animal experiments. An elaborate directive, Declaration of Helsinki, primarily focuses on human research ethics but has principle related o animal research ethics as well [2]. Likewise, another Convention on International Trade in Endangered Species of Wild Fauna and Flora also called as CITES, deals with the trade of endangered animals ensuring that any research which involves endangered species is conducted ethically with proper permits and prevents illegal and unethical exploitation of animals [3]. Last but not the least, the ARRIVE guidelines provide a checklist of essential information which must be included while publishing the research data which describes animal experiments, promotes transparency and improve the quality of reporting in the animal research. The current global conditions necessitate ethical consciousness in zoological research. These consid

Although Pakistan has rich biodiversity, many groups are poorly known, particularly insects. To address this gap, we employed DNA barcoding to survey its insect diversity. Specimens obtained through diverse collecting methods at 1,858 sites across Pakistan from 2010-2019 were examined for sequence variation in the 658 bp barcode region of the cytochrome c oxidase 1 (COI) gene. Sequences from nearly 49,000 specimens were assigned to 6,590 Barcode Index Numbers (BINs), a proxy for species, and most (88%) also possessed a representative image on the Barcode of Life Data System (BOLD). By coupling morphological inspections with barcode matches on BOLD, every BIN was assigned to an order (19) and most (99.8%) were placed to a family (362). However, just 40% of the BINs were assigned to a genus (1,375) and 21% to a species (1,364). Five orders (Coleoptera, Diptera, Hemiptera, Hymenoptera, Lepidoptera) accounted for 92% of the specimens and BINs. More than half of the BINs (59%) are so far only known from Pakistan, but others have also been reported from Bangladesh (13%), India (12%), and China (8%). Representing the first DNA barcode survey of the insect fauna in any South Asian country, this study provides the foundation for a complete inventory of the insect fauna in Pakistan while also contributing to the global DNA barcode reference library.

With an estimated 21 million people, Pakistan is a heavily populated, developing nation. The general population's lack of awareness, an unclean lifestyle, and unsanitary circumstances in populated regions are the main causes of Pakistan's endemic prevalence of various infectious and non-communicable diseases. Studies on the prevalence and incidence of cancer in Pakistan are extremely rare. Only Karachi and Lahore previously had cancer registers, but in 2015 the Pakistan Health Research Council (PHRC) in Islamabad launched a national cancer registry. Females have a significantly higher age-standardized ratio for cancer (172/100000) than males have (145/100000). Recently, Pakistan has seen 150,000 new cases of cancer, with 60–80 percent of patients dying. In Pakistan, between 7000 and 7500 kids are diagnosed with cancer each year. In Pakistan, communicable illnesses and malnutrition are the leading causes of child mortality. Better diagnostic tools have led to cancer being a significant cause of morbidity and mortality in children. Data readily available indicates that 10% of all cancer cases reported in 2017 were juvenile malignancies. According to Pakistan's Karachi Cancer Registry, the two most common children cancers are leukaemia (31%) and lymphomas (20%). According to data from the Punjab Cancer Registry, lymphomas (31%) are more common than leukaemia (23%) overall. The recently established PHRC National Cancer Registry has very little information available at this time that demonstrates the prevalence of children cancers. An accurate surveillance system for cancer incidence and death is absolutely necessary. Population-based cancer registries are quite rare in the nation. There ought to be more cancer registries in a nation with more than 21 million citizens. In Pakistan, the most often diagnosed cancers are head and neck carcinoma, colon, prostate, lung, breast, and liver cancers. Different malignancies have varying chances of being cured. But every malignancy

With an estimated 21 million people, Pakistan is a heavily populated, developing nation. The general population's lack of awareness, an unclean lifestyle, and unsanitary circumstances in populated regions are the main causes of Pakistan's endemic prevalence of various infectious and non-communicable diseases. Studies on the prevalence and incidence of cancer in Pakistan are extremely rare. Only Karachi and Lahore previously had cancer registers, but in 2015 the Pakistan Health Research Council (PHRC) in Islamabad launched a national cancer registry. Females have a significantly higher age-standardized ratio for cancer (172/100000) than males have (145/100000). Recently, Pakistan has seen 150,000 new cases of cancer, with 60–80 percent of patients dying. In Pakistan, between 7000 and 7500 kids are diagnosed with cancer each year. In Pakistan, communicable illnesses and malnutrition are the leading causes of child mortality. Better diagnostic tools have led to cancer being a significant cause of morbidity and mortality in children. Data readily available indicates that 10% of all cancer cases reported in 2017 were juvenile malignancies. According to Pakistan's Karachi Cancer Registry, the two most common children cancers are leukaemia (31%) and lymphomas (20%). According to data from the Punjab Cancer Registry, lymphomas (31%) are more common than leukaemia (23%) overall. The recently established PHRC National Cancer Registry has very little information available at this time that demonstrates the prevalence of children cancers. An accurate surveillance system for cancer incidence and death is absolutely necessary. Population-based cancer registries are quite rare in the nation. There ought to be more cancer registries in a nation with more than 21 million citizens. In Pakistan, the most often diagnosed cancers are head and neck carcinoma, colon, prostate, lung, breast, and liver cancers. Different malignancies have varying chances of being cured. But every malignancy

With an estimated 21 million people, Pakistan is a heavily populated, developing nation. The general population's lack of awareness, an unclean lifestyle, and unsanitary circumstances in populated regions are the main causes of Pakistan's endemic prevalence of various infectious and non-communicable diseases. Studies on the prevalence and incidence of cancer in Pakistan are extremely rare. Only Karachi and Lahore previously had cancer registers, but in 2015 the Pakistan Health Research Council (PHRC) in Islamabad launched a national cancer registry. Females have a significantly higher age-standardized ratio for cancer (172/100000) than males have (145/100000). Recently, Pakistan has seen 150,000 new cases of cancer, with 60–80 percent of patients dying. In Pakistan, between 7000 and 7500 kids are diagnosed with cancer each year. In Pakistan, communicable illnesses and malnutrition are the leading causes of child mortality. Better diagnostic tools have led to cancer being a significant cause of morbidity and mortality in children. Data readily available indicates that 10% of all cancer cases reported in 2017 were juvenile malignancies. According to Pakistan's Karachi Cancer Registry, the two most common children cancers are leukaemia (31%) and lymphomas (20%). According to data from the Punjab Cancer Registry, lymphomas (31%) are more common than leukaemia (23%) overall. The recently established PHRC National Cancer Registry has very little information available at this time that demonstrates the prevalence of children cancers. An accurate surveillance system for cancer incidence and death is absolutely necessary. Population-based cancer registries are quite rare in the nation. There ought to be more cancer registries in a nation with more than 21 million citizens. In Pakistan, the most often diagnosed cancers are head and neck carcinoma, colon, prostate, lung, breast, and liver cancers. Different malignancies have varying chances of being cured. But every malignancy

With an estimated 21 million people, Pakistan is a heavily populated, developing nation. The general population's lack of awareness, an unclean lifestyle, and unsanitary circumstances in populated regions are the main causes of Pakistan's endemic prevalence of various infectious and non-communicable diseases. Studies on the prevalence and incidence of cancer in Pakistan are extremely rare. Only Karachi and Lahore previously had cancer registers, but in 2015 the Pakistan Health Research Council (PHRC) in Islamabad launched a national cancer registry. Females have a significantly higher age-standardized ratio for cancer (172/100000) than males have (145/100000). Recently, Pakistan has seen 150,000 new cases of cancer, with 60–80 percent of patients dying. In Pakistan, between 7000 and 7500 kids are diagnosed with cancer each year. In Pakistan, communicable illnesses and malnutrition are the leading causes of child mortality. Better diagnostic tools have led to cancer being a significant cause of morbidity and mortality in children. Data readily available indicates that 10% of all cancer cases reported in 2017 were juvenile malignancies. According to Pakistan's Karachi Cancer Registry, the two most common children cancers are leukaemia (31%) and lymphomas (20%). According to data from the Punjab Cancer Registry, lymphomas (31%) are more common than leukaemia (23%) overall. The recently established PHRC National Cancer Registry has very little information available at this time that demonstrates the prevalence of children cancers. An accurate surveillance system for cancer incidence and death is absolutely necessary. Population-based cancer registries are quite rare in the nation. There ought to be more cancer registries in a nation with more than 21 million citizens. In Pakistan, the most often diagnosed cancers are head and neck carcinoma, colon, prostate, lung, breast, and liver cancers. Different malignancies have varying chances of being cured. But every malignancy

With an estimated 21 million people, Pakistan is a heavily populated, developing nation. The general population's lack of awareness, an unclean lifestyle, and unsanitary circumstances in populated regions are the main causes of Pakistan's endemic prevalence of various infectious and non-communicable diseases. Studies on the prevalence and incidence of cancer in Pakistan are extremely rare. Only Karachi and Lahore previously had cancer registers, but in 2015 the Pakistan Health Research Council (PHRC) in Islamabad launched a national cancer registry. Females have a significantly higher age-standardized ratio for cancer (172/100000) than males have (145/100000). Recently, Pakistan has seen 150,000 new cases of cancer, with 60–80 percent of patients dying. In Pakistan, between 7000 and 7500 kids are diagnosed with cancer each year. In Pakistan, communicable illnesses and malnutrition are the leading causes of child mortality. Better diagnostic tools have led to cancer being a significant cause of morbidity and mortality in children. Data readily available indicates that 10% of all cancer cases reported in 2017 were juvenile malignancies. According to Pakistan's Karachi Cancer Registry, the two most common children cancers are leukaemia (31%) and lymphomas (20%). According to data from the Punjab Cancer Registry, lymphomas (31%) are more common than leukaemia (23%) overall. The recently established PHRC National Cancer Registry has very little information available at this time that demonstrates the prevalence of children cancers. An accurate surveillance system for cancer incidence and death is absolutely necessary. Population-based cancer registries are quite rare in the nation. There ought to be more cancer registries in a nation with more than 21 million citizens. In Pakistan, the most often diagnosed cancers are head and neck carcinoma, colon, prostate, lung, breast, and liver cancers. Different malignancies have varying chances of being cured. But every malignancy

Although Pakistan has rich biodiversity, many groups are poorly known, particularly insects. To address this gap, we employed DNA barcoding to survey its insect diversity. Specimens obtained through diverse collecting methods at 1,858 sites across Pakistan from 2010-2019 were examined for sequence variation in the 658 bp barcode region of the cytochrome c oxidase 1 (COI) gene. Sequences from nearly 49,000 specimens were assigned to 6,590 Barcode Index Numbers (BINs), a proxy for species, and most (88%) also possessed a representative image on the Barcode of Life Data System (BOLD). By coupling morphological inspections with barcode matches on BOLD, every BIN was assigned to an order (19) and most (99.8%) were placed to a family (362). However, just 40% of the BINs were assigned to a genus (1,375) and 21% to a species (1,364). Five orders (Coleoptera, Diptera, Hemiptera, Hymenoptera, Lepidoptera) accounted for 92% of the specimens and BINs. More than half of the BINs (59%) are so far only known from Pakistan, but others have also been reported from Bangladesh (13%), India (12%), and China (8%). Representing the first DNA barcode survey of the insect fauna in any South Asian country, this study provides the foundation for a complete inventory of the insect fauna in Pakistan while also contributing to the global DNA barcode reference library.

Although Pakistan has rich biodiversity, many groups are poorly known, particularly insects. To address this gap, we employed DNA barcoding to survey its insect diversity. Specimens obtained through diverse collecting methods at 1,858 sites across Pakistan from 2010-2019 were examined for sequence variation in the 658 bp barcode region of the cytochrome c oxidase 1 (COI) gene. Sequences from nearly 49,000 specimens were assigned to 6,590 Barcode Index Numbers (BINs), a proxy for species, and most (88%) also possessed a representative image on the Barcode of Life Data System (BOLD). By coupling morphological inspections with barcode matches on BOLD, every BIN was assigned to an order (19) and most (99.8%) were placed to a family (362). However, just 40% of the BINs were assigned to a genus (1,375) and 21% to a species (1,364). Five orders (Coleoptera, Diptera, Hemiptera, Hymenoptera, Lepidoptera) accounted for 92% of the specimens and BINs. More than half of the BINs (59%) are so far only known from Pakistan, but others have also been reported from Bangladesh (13%), India (12%), and China (8%). Representing the first DNA barcode survey of the insect fauna in any South Asian country, this study provides the foundation for a complete inventory of the insect fauna in Pakistan while also contributing to the global DNA barcode reference library.

The most significant risk factor for the development of cardiovascular disease is thought to be hypertension. One of the key factors behind the emergence of hypertension, oxidative stress, has attracted attention. Reactive oxygen species (ROS) may play a part in the mechanism underlying hypertension because they are crucial to maintaining the vascular wall's equilibrium. Additionally, mechanical forces that rise with hypertension may contribute to increased ROS generation. Increased intracellular calcium concentration causes ROS-induced vasoconstriction, which contributes to the development of hypertension. Vasomotor tone depends on a precise balance between vasoconstrictor and vasodilator forces that are produced by the interaction of the blood and vascular wall components. Oxidative stress can change any of these forces. These results have sparked interest in antihypertensive treatments that aim to reduce ROS production and/or boost nitric oxide (NO) bioavailability. A strong water-soluble antioxidant, Vitamin C acts as an enzyme modulator on the arterial wall, increasing endothelial nitric oxide synthase (eNOS) and decreasing NADPH oxidase (NOX). Antioxidant therapy has been proven to improve vascular function and lower blood pressure in both animal models of hypertension and human hypertension [1, 2]. Vascular dilatation may benefit from vitamin C, probably due to its antioxidant effects on NO. Another important lipid-soluble antioxidant, Vitamin E, has drawn a lot of interest due to its antioxidant properties. A high dietary vitamin E intake is associated with a lower incidence of cardiovascular disease and a growing body of research suggests that vitamin E can modify biological processes without affecting its antioxidant capacity. The existing experimental data demonstrates that vitamin E is capable of dose-dependently controlling the production of superoxide and hydrogen peroxide in the mitochondria which in turn shows anti-hypertensive effects [3].

The most significant risk factor for the development of cardiovascular disease is thought to be hypertension. One of the key factors behind the emergence of hypertension, oxidative stress, has attracted attention. Reactive oxygen species (ROS) may play a part in the mechanism underlying hypertension because they are crucial to maintaining the vascular wall's equilibrium. Additionally, mechanical forces that rise with hypertension may contribute to increased ROS generation. Increased intracellular calcium concentration causes ROS-induced vasoconstriction, which contributes to the development of hypertension. Vasomotor tone depends on a precise balance between vasoconstrictor and vasodilator forces that are produced by the interaction of the blood and vascular wall components. Oxidative stress can change any of these forces. These results have sparked interest in antihypertensive treatments that aim to reduce ROS production and/or boost nitric oxide (NO) bioavailability. A strong water-soluble antioxidant, Vitamin C acts as an enzyme modulator on the arterial wall, increasing endothelial nitric oxide synthase (eNOS) and decreasing NADPH oxidase (NOX). Antioxidant therapy has been proven to improve vascular function and lower blood pressure in both animal models of hypertension and human hypertension [1, 2]. Vascular dilatation may benefit from vitamin C, probably due to its antioxidant effects on NO. Another important lipid-soluble antioxidant, Vitamin E, has drawn a lot of interest due to its antioxidant properties. A high dietary vitamin E intake is associated with a lower incidence of cardiovascular disease and a growing body of research suggests that vitamin E can modify biological processes without affecting its antioxidant capacity. The existing experimental data demonstrates that vitamin E is capable of dose-dependently controlling the production of superoxide and hydrogen peroxide in the mitochondria which in turn shows anti-hypertensive effects [3].

The most significant risk factor for the development of cardiovascular disease is thought to be hypertension. One of the key factors behind the emergence of hypertension, oxidative stress, has attracted attention. Reactive oxygen species (ROS) may play a part in the mechanism underlying hypertension because they are crucial to maintaining the vascular wall's equilibrium. Additionally, mechanical forces that rise with hypertension may contribute to increased ROS generation. Increased intracellular calcium concentration causes ROS-induced vasoconstriction, which contributes to the development of hypertension. Vasomotor tone depends on a precise balance between vasoconstrictor and vasodilator forces that are produced by the interaction of the blood and vascular wall components. Oxidative stress can change any of these forces. These results have sparked interest in antihypertensive treatments that aim to reduce ROS production and/or boost nitric oxide (NO) bioavailability. A strong water-soluble antioxidant, Vitamin C acts as an enzyme modulator on the arterial wall, increasing endothelial nitric oxide synthase (eNOS) and decreasing NADPH oxidase (NOX). Antioxidant therapy has been proven to improve vascular function and lower blood pressure in both animal models of hypertension and human hypertension [1, 2]. Vascular dilatation may benefit from vitamin C, probably due to its antioxidant effects on NO. Another important lipid-soluble antioxidant, Vitamin E, has drawn a lot of interest due to its antioxidant properties. A high dietary vitamin E intake is associated with a lower incidence of cardiovascular disease and a growing body of research suggests that vitamin E can modify biological processes without affecting its antioxidant capacity. The existing experimental data demonstrates that vitamin E is capable of dose-dependently controlling the production of superoxide and hydrogen peroxide in the mitochondria which in turn shows anti-hypertensive effects [3].

The most significant risk factor for the development of cardiovascular disease is thought to be hypertension. One of the key factors behind the emergence of hypertension, oxidative stress, has attracted attention. Reactive oxygen species (ROS) may play a part in the mechanism underlying hypertension because they are crucial to maintaining the vascular wall's equilibrium. Additionally, mechanical forces that rise with hypertension may contribute to increased ROS generation. Increased intracellular calcium concentration causes ROS-induced vasoconstriction, which contributes to the development of hypertension. Vasomotor tone depends on a precise balance between vasoconstrictor and vasodilator forces that are produced by the interaction of the blood and vascular wall components. Oxidative stress can change any of these forces. These results have sparked interest in antihypertensive treatments that aim to reduce ROS production and/or boost nitric oxide (NO) bioavailability. A strong water-soluble antioxidant, Vitamin C acts as an enzyme modulator on the arterial wall, increasing endothelial nitric oxide synthase (eNOS) and decreasing NADPH oxidase (NOX). Antioxidant therapy has been proven to improve vascular function and lower blood pressure in both animal models of hypertension and human hypertension [1, 2]. Vascular dilatation may benefit from vitamin C, probably due to its antioxidant effects on NO. Another important lipid-soluble antioxidant, Vitamin E, has drawn a lot of interest due to its antioxidant properties. A high dietary vitamin E intake is associated with a lower incidence of cardiovascular disease and a growing body of research suggests that vitamin E can modify biological processes without affecting its antioxidant capacity. The existing experimental data demonstrates that vitamin E is capable of dose-dependently controlling the production of superoxide and hydrogen peroxide in the mitochondria which in turn shows anti-hypertensive effects [3].

The toll of workplace bullying is immense, yet, similarly as with an iceberg, its scope, scale and implications tend to remain underestimated. Several ways of assessing the prevalence of workplace bullying have been proposed in the literature. The most frequently discussed are the ‘subjective method’ assessing individuals’ perceptions of being a victim and the questionnaire, i.e., criterion-based, methods, including Negative Acts Questionnaire (NAQ) and Leymann Inventory of Psychological Terror (LIPT). Since in both cases culture plays a profound role as a mediating factor in the process of identifying, collecting, and processing data, the applicability of these methods across cultures and countries has several limitations. At this stage, it is impossible to determine the impact of the implicit cultural-bias that these methods entail on the research outcomes. This would be possible if an alternative workplace bullying scale (WBS) was at hand and, consequently, a comparative analysis was conducted. This paper, drawing from a study conducted at higher education institutions (HEI) across Pakistan, addresses this issue by devising an alternative WBS. The value added of this paper is three-fold, i.e., it elaborates on the study and the specific methods employed to prove the validity and relevance of the alternative WBS. Moreover, by so doing, it addresses some of the limitations that other methods measuring the prevalence of workplace bullying display. As a result, it adds to the researchers’ and administrators’ toolkit as regards research and policies aimed at mitigating the scope and scale of bullying at HEIs across cultures and countries.

Although workplace bullying is a well-researched phenomenon, the specific way it unfolds in higher education institutions (HEI) remains largely underdiscussed. Based on the outcomes of a survey conducted across HEI in Pakistan, by reference to structural equation modeling, using Amos-20, this paper not only adds to our understanding of the scope and features of bullying in HEI, but also suggests strategies employers and victims could employ to cope with the adverse implications of bullying. The key findings of this research are: (i) a positive correlation exists between the degree of workplace bullying and strain levels; (ii) more frequently than not, female employees, younger employees, and employees in junior positions are victims of bullying; (iii) bullying and strain can be fully mediated only when both emotion-focused and problem-focused coping strategies are employed in synergy. In brief, although research findings elaborated in this paper draw from the specific case of HEI in Pakistan, this paper makes a case for more research, vigilance and action to understand the scale of the phenomenon in academia and to undertake concerted action to mitigate its adverse impact on specific individuals and HEI themselves.

The toll of workplace bullying is immense, yet, similarly as with an iceberg, its scope, scale and implications tend to remain underestimated. Several ways of assessing the prevalence of workplace bullying have been proposed in the literature. The most frequently discussed are the ‘subjective method’ assessing individuals’ perceptions of being a victim and the questionnaire, i.e., criterion-based, methods, including Negative Acts Questionnaire (NAQ) and Leymann Inventory of Psychological Terror (LIPT). Since in both cases culture plays a profound role as a mediating factor in the process of identifying, collecting, and processing data, the applicability of these methods across cultures and countries has several limitations. At this stage, it is impossible to determine the impact of the implicit cultural-bias that these methods entail on the research outcomes. This would be possible if an alternative workplace bullying scale (WBS) was at hand and, consequently, a comparative analysis was conducted. This paper, drawing from a study conducted at higher education institutions (HEI) across Pakistan, addresses this issue by devising an alternative WBS. The value added of this paper is three-fold, i.e., it elaborates on the study and the specific methods employed to prove the validity and relevance of the alternative WBS. Moreover, by so doing, it addresses some of the limitations that other methods measuring the prevalence of workplace bullying display. As a result, it adds to the researchers’ and administrators’ toolkit as regards research and policies aimed at mitigating the scope and scale of bullying at HEIs across cultures and countries.

Although workplace bullying is a well-researched phenomenon, the specific way it unfolds in higher education institutions (HEI) remains largely underdiscussed. Based on the outcomes of a survey conducted across HEI in Pakistan, by reference to structural equation modeling, using Amos-20, this paper not only adds to our understanding of the scope and features of bullying in HEI, but also suggests strategies employers and victims could employ to cope with the adverse implications of bullying. The key findings of this research are: (i) a positive correlation exists between the degree of workplace bullying and strain levels; (ii) more frequently than not, female employees, younger employees, and employees in junior positions are victims of bullying; (iii) bullying and strain can be fully mediated only when both emotion-focused and problem-focused coping strategies are employed in synergy. In brief, although research findings elaborated in this paper draw from the specific case of HEI in Pakistan, this paper makes a case for more research, vigilance and action to understand the scale of the phenomenon in academia and to undertake concerted action to mitigate its adverse impact on specific individuals and HEI themselves.